← Back
Data updated: Mar 10, 2026
SAWAI USA
Cardiovascular
SAWAI USA is a generic drug manufacturer focused on Cardiovascular.
2017
Since
3
Drugs
-
Trials
49
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
MIRABEGRON 2026-01-20
MIRABEGRON 2025-12-29
Manufacturing (CMC)
MIRABEGRON 2025-11-04
MIRABEGRON 2025-09-24
MIRABEGRON 2025-06-30
PITAVASTATIN CALCIUM 2025-06-13
Labeling
MIRABEGRON 2025-05-06
DIMETHYL FUMARATE 2025-01-22
Labeling
DIMETHYL FUMARATE 2025-01-14
Labeling
DIMETHYL FUMARATE 2025-01-06
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2017-02-03
- Latest
- 2025-05-06
- Applications
- 4